{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T02:58:20Z","timestamp":1789095500446,"version":"build-2803163510"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T00:00:00Z","timestamp":1590624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T00:00:00Z","timestamp":1590624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocr Pathol"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s12022-020-09631-4","type":"journal-article","created":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T18:03:32Z","timestamp":1590689012000},"page":"218-230","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Hereditary Parathyroid Disease: Sometimes Pathologists Do Not Know What They Are Missing"],"prefix":"10.1007","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4281-7134","authenticated-orcid":false,"given":"John","family":"Turchini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,28]]},"reference":[{"key":"9631_CR1","volume-title":"WHO classification of endocrine organs","author":"RV Lloyd","year":"2017","unstructured":"Lloyd RV, Osamura RY, Kl\u00f6ppel G, Rosai J. WHO classification of endocrine organs. Lyon IARC Press, 2017."},{"key":"9631_CR2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/his.13306","volume":"72","author":"R DeLellis","year":"2018","unstructured":"DeLellis R, Mangray S. (2018) Heritable forms of Hyperparathyroidism: a current perspective. Histopathology 72, 117-132.","journal-title":"Histopathology"},{"issue":"Suppl. 2","key":"9631_CR3","first-page":"N37","volume":"17","author":"SJ Marx","year":"2002","unstructured":"Marx SJ, Simonds WF, Agarwal SK et al. (2002) Hyperparathyroidism in hereditary syndromes: special expressions and special managements. J. Bone Miner. Res.17(Suppl. 2); N37\u2013N43.2.","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"9631_CR4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/PAS.0000000000001017","volume":"43","author":"A Gill","year":"2019","unstructured":"Gill A, Lim G, Cheung VKY et al. (2019) Parafibromin deficient (HPT-JT Type, CDC73 mutated) parathyroid tumors demonstrate distinctive morphologic features. Am J Surg Pathol 43(1); 35-46","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"9631_CR5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000505498","volume":"36","author":"J Manoharan","year":"2020","unstructured":"Manoharan J, Bollmann C, Kann PH, Di Fazio P, Bartsch DK, Albers M.B. (2020) Gender Differences in Multiple Endocrine Neoplasia Type 1: Implications for Screening? Visc Med. Feb;36(1):3-9.","journal-title":"Visc Med. Feb"},{"issue":"11","key":"9631_CR6","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1210\/jc.2013-4491","volume":"99","author":"T Lassen","year":"2014","unstructured":"T. Lassen, L. Friis-Hansen, \u00c5. K. Rasmussen, U. Knigge, U. Feldt-Rasmussen. (2014) Primary Hyperparathyroidism in Young People. When Should We Perform Genetic Testing for Multiple Endocrine Neoplasia 1 (MEN-1)?, The Journal of Clinical Endocrinology & Metabolism 99(11): 3983\u20133987","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"key":"9631_CR7","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1750-1172-1-38","volume":"1","author":"F Marini","year":"2006","unstructured":"Marini F, Falchetti A, Del Monte F, et al. (2006) Multiple endocrine neoplasia type 1. Orphanet J Rare Dis. 1:38.","journal-title":"Orphanet J Rare Dis."},{"key":"9631_CR8","doi-asserted-by":"crossref","first-page":"326","DOI":"10.14310\/horm.2002.1325","volume":"10","author":"C del Pozo","year":"2011","unstructured":"del Pozo, C, Garc\u00eda-Pascual, L, Balsells, M et al. (2011) Parathyroid carcinoma in multiple endocrine neoplasia type 1. Case report and review of the literature. Hormones 10, 326\u2013331.","journal-title":"Hormones"},{"key":"9631_CR9","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1136\/jclinpath-2015-203186","volume":"68","author":"K Duan","year":"2015","unstructured":"Duan K, Gomez Hernandez K, Mete O. (2015) Clinicopathological correlates of hyperparathyroidism. Journal of Clinical Pathology 68:771-787.","journal-title":"Journal of Clinical Pathology"},{"issue":"8","key":"9631_CR10","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/imj.14394","volume":"49","author":"J McDonnell","year":"2019","unstructured":"McDonnell J, Gild M, Clifton-Bligh R, Robinson B. (2019) Multiple endocrine neoplasia: An update. Internal medicine journal. 49(8), 954-961.","journal-title":"Internal medicine journal."},{"key":"9631_CR11","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1038\/modpathol.2010.132","volume":"24","author":"R DeLellis","year":"2011","unstructured":"DeLellis R. (2011) Parathyroid tumours and related disorders. Modern Pathology 24, S78-S93.","journal-title":"Modern Pathology"},{"key":"9631_CR12","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/joim.12523","volume":"280","author":"RV Thakker","year":"2016","unstructured":"Thakker RV. (2016) Genetics of parathyroid tumours. J. Int. Med. 280; 574\u2013583.","journal-title":"J. Int. Med."},{"key":"9631_CR13","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mce.2013.08.002","volume":"386","author":"RV Thakker","year":"2014","unstructured":"Thakker RV. (2014) Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4). Mol. Cell. Endocrinol. 386;2\u201315.","journal-title":"Mol. Cell. Endocrinol."},{"key":"9631_CR14","doi-asserted-by":"crossref","first-page":"484","DOI":"10.7326\/0003-4819-129-6-199809150-00011","volume":"129","author":"S Marx","year":"1998","unstructured":"Marx S, Spiegel AM, Skarulis MC, Doppman JL, Collins FS, Liotta LA. (1998) Multiple endocrine neoplasia type 1: clinical and genetic topics. Ann. Intern. Med. 129; 484\u2013494.","journal-title":"Ann. Intern. Med."},{"key":"9631_CR15","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.beem.2010.07.003","volume":"24","author":"RV Thakker","year":"2010","unstructured":"Thakker RV. (2010) Multiple endocrine neoplasia type 1(MEN1). Best Pract. Res. Clin. Endocrinol. Metab. 24; 355\u2013370.","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"9631_CR16","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1097\/01.pas.0000209827.39477.4f","volume":"30","author":"AJ Gill","year":"2006","unstructured":"Gill AJ, Clarkson A, Gimm O, et al. (2006) Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome related adenomas from sporadic parathyroid adenomas and hyperplasias. Am J Surg Pathol. 30:1140\u20131149.","journal-title":"Am J Surg Pathol."},{"key":"9631_CR17","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s12022-013-9294-3","volume":"25","author":"AJ Gill","year":"2014","unstructured":"Gill AJ. (2014) Understanding the genetic basis of parathyroid carcinoma. Endocr Pathol. 25:30\u201334.","journal-title":"Endocr Pathol."},{"issue":"2","key":"9631_CR18","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1245\/s10434-013-3288-8","volume":"21","author":"S Kruijff","year":"2014","unstructured":"Kruijff S, Sidhu SB, Sywak MS, Gill AJ, Delbridge LW (2014) Negative parafibromin staining predicts malignant behavior in atypical parathyroid adenomas. Ann Surg Oncol. Feb;21(2):426-33","journal-title":"Ann Surg Oncol. Feb"},{"key":"9631_CR19","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1210\/jc.2008-1740","volume":"94","author":"VM Howell","year":"2009","unstructured":"Howell VM, Gill A, Clarkson A, et al. (2009) Accuracy of combined Protein Gene Product 9.5 and parafibromin markers for immunohistochemical diagnosis of parathyroid carcinoma. J Clin Endocrinol Metab. 94:434\u201341.","journal-title":"J Clin Endocrinol Metab."},{"key":"9631_CR20","doi-asserted-by":"crossref","first-page":"E360","DOI":"10.1210\/jc.2014-3238","volume":"100","author":"W Yu","year":"2015","unstructured":"Yu W, McPherson JR, Stevenson M, et al. (2015) Whole-exome sequencing studies of parathyroid carcinomas reveal novel PRUNE2 mutations, distinctive mutational spectra related to APOBEC-catalyzed DNA mutagenesis and mutational enrichment in kinases associated with cell migration and invasion. J Clin Endocrinol Metab. 100:E360\u2013E364.","journal-title":"J Clin Endocrinol Metab."},{"key":"9631_CR21","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1136\/jmg.40.9.657","volume":"40","author":"VM Howell","year":"2003","unstructured":"Howell VM, Haven CJ, Kahnoski K, et al. (2003) HRPT2mutations are associated with malignancy in sporadic parathyroid tumours. J Med Genet. 40:657\u2013663.","journal-title":"J Med Genet."},{"key":"9631_CR22","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1056\/NEJMoa031237","volume":"349","author":"T Shattuck","year":"2003","unstructured":"Shattuck T, Stiina V, Obara T, et al. (2003) Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. N Engl J Med. 349:1722\u20131729.","journal-title":"N Engl J Med."},{"key":"9631_CR23","doi-asserted-by":"crossref","first-page":"5583","DOI":"10.1210\/jc.2004-0294","volume":"89","author":"F Cetani","year":"2004","unstructured":"Cetani F, Pardi E, Borsari S, et al. (2004) Genetic analyses of HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumours. J Clin Endocinol Metab. 89:5583\u20135591.","journal-title":"J Clin Endocinol Metab."},{"key":"9631_CR24","doi-asserted-by":"crossref","first-page":"5015","DOI":"10.1210\/jc.2005-0717","volume":"90","author":"L Krebs","year":"2005","unstructured":"Krebs L, Shattuck TM, Arnold A. (2005) HRPT mutation analysis of typical sporadic parathyroid adenomas. J Clin Endocinol Metab. 90:5015\u20135017.","journal-title":"J Clin Endocinol Metab."},{"key":"9631_CR25","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s00423-009-0511-y","volume":"394","author":"M Iacobone","year":"2009","unstructured":"Iacobone M, Masi G, Barzon L et al. (2009) Hyperparathyroidism-jaw tumour syndrome: a report of three large kindred. Langenbecks Arch. Surg. 394; 817\u2013825.","journal-title":"Langenbecks Arch. Surg."},{"key":"9631_CR26","first-page":"1449","volume":"85","author":"CJ Haven","year":"2000","unstructured":"Haven CJ, Wong FK, vanDam EW et al. (2000) A genotypic and histopathologic study of a large Dutch kindred with hyper-parathyroidism-jaw tumour syndrome. J. Clin. Endocrinol. Metab. 85; 1449\u20131454","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9631_CR27","doi-asserted-by":"crossref","first-page":"4534","DOI":"10.1210\/jc.2017-01249","volume":"102","author":"K van der Tuin","year":"2017","unstructured":"van der Tuin K, Tops CMJ, Adank MA, et al. (2017) CDC73-related disorders: clinical manifestations and case detection in primary hyperparathyroidism. JClinEndocrinol Metab. 102:4534\u20134454.","journal-title":"JClinEndocrinol Metab."},{"issue":"1","key":"9631_CR28","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1365-2796.2004.01421.x","volume":"257","author":"KJ Bradley","year":"2005","unstructured":"Bradley KJ, Hobbs MR, Buley RB et al. (2005) Uterine tumours are a phenotypic manifestation of the hyperparathyroid. J Intern Med. Jan;257(1):18-26","journal-title":"J Intern Med. Jan"},{"key":"9631_CR29","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.surg.2014.08.004","volume":"156","author":"A Mehta","year":"2014","unstructured":"Mehta A, Patel D, Rosenberg A, et al. (2014) Hyperparathyroidism-jaw tumor syndrome: results of operative management. Surgery. 156:1315\u20131324.","journal-title":"Surgery."},{"key":"9631_CR30","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1590\/S0004-27302008000800003","volume":"52","author":"LG Silveira","year":"2008","unstructured":"Silveira LG, Dias EP, Marinho BC, et al. (2008) HRPT2-related familial isolated hyperparathyroidism: could molecular studies direct the surgical approach? Arq Bras Endocrinol Metabol. 52:1211\u20131220.","journal-title":"Arq Bras Endocrinol Metabol."},{"key":"9631_CR31","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/PAP.0b013e3180ca8ad0","volume":"14","author":"S Mangray","year":"2007","unstructured":"Mangray S, Delellis RA. (2007) Parafibromin in the diagnosis of parathyroid carcinoma. Adv Anatomic Pathol. 14:299\u2013301.","journal-title":"Adv Anatomic Pathol."},{"key":"9631_CR32","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.jamcollsurg.2014.10.007","volume":"220","author":"CE Quinn","year":"2015","unstructured":"Quinn CE, Healy J, Lebastchi AH, et al. (2015) Modern experience with aggressive parathyroid tumors in a high-volume. New England referral center. J Am Coll Surg. 220:1054\u20131062.","journal-title":"J Am Coll Surg."},{"key":"9631_CR33","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s12022-008-9050-2","volume":"19","author":"RA Delellis","year":"2008","unstructured":"Delellis RA. (2008) Challenging lesions in the differential diagnosis of endocrine tumors: parathyroid carcinoma. Endocr Pathol. 19: 221\u2013225.","journal-title":"Endocr Pathol."},{"issue":"5","key":"9631_CR34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0097994","volume":"9","author":"G Masi","year":"2014","unstructured":"Masi G, Iacobone M, Sinigaglia A, Mantelli B, Pennelli G, Castagliuolo I, et al. (2014) Characterization of a New CDC73 Missense Mutation that Impairs Parafibromin Expression and Nucleolar Localization. PLoS ONE 9(5): e97994","journal-title":"PLoS ONE"},{"key":"9631_CR35","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00428-010-1032-3","volume":"459","author":"CC Juhlin","year":"2011","unstructured":"Juhlin, C.C., Haglund, F., Obara, T. et al. (2011) Absence of nucleolar parafibromin immunoreactivity in subsets of parathyroid malignant tumours. Virchows Arch 459, 47\u201353.","journal-title":"Virchows Arch"},{"key":"9631_CR36","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00423-015-1342-7","volume":"400","author":"M Iacobone","year":"2015","unstructured":"Iacobone M, Carnaille B, Palazzo FF, et al. (2015) Hereditary hyper-parathyroidism\u2014a consensus report of the European Society of Endocrine Surgeons (ESES). Langenbecks Arch Surg. 400:867\u2013886.","journal-title":"Langenbecks Arch Surg."},{"issue":"6","key":"9631_CR37","doi-asserted-by":"crossref","first-page":"841","DOI":"10.2169\/internalmedicine.9509-17","volume":"57","author":"K Koikawa","year":"2018","unstructured":"Koikawa K, Okada Y, Mori H, Kawaguchi M, Uchino S, Tanaka Y. (2018) Hyperparathyroidism-jaw Tumor Syndrome Confirmed by Preoperative Genetic Testing. Intern Med. 57(6):841\u2013844.","journal-title":"Intern Med."},{"key":"9631_CR38","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0002-9343(85)90455-3","volume":"78","author":"SJ Marx","year":"1985","unstructured":"Marx SJ, Fraser D, Rapoport A. (1985) Familial hypocalciuric hypercalcemia: mild expression of the gene in heterozygotes and severe expression in homozygotes. Am. J. Med. 78;15\u201322.","journal-title":"Am. J. Med."},{"key":"9631_CR39","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1210\/jc.2015-3442","volume":"101","author":"R Vargas-Poussou","year":"2016","unstructured":"Vargas-Poussou R, Mansour-Hendili L, Baron S et al. (2016) Familial hypocalciuric hypercalcemia types 1 and 3 and primary hyperparathyroidism: similarities and differences. J. Clin. Endocrinol. Metab. 101; 2185\u20132195.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9631_CR40","doi-asserted-by":"crossref","first-page":"R127","DOI":"10.1530\/JME-16-0124","volume":"57","author":"F Hannan","year":"2016","unstructured":"Hannan F, Babinsky VN, Thakker RV. (2016) Disorders of the calcium sensing receptor and partner proteins: insights into the molecular basis of calcium homeostasis. J. Mol. Endocrinol. 57; R127\u2013R142.","journal-title":"J. Mol. Endocrinol."},{"key":"9631_CR41","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1258\/0004563042466802","volume":"41","author":"IR Gunn","year":"2004","unstructured":"Gunn IR, Gaffney D. (2004) Clinical and laboratory features of calcium-sensing receptor disorders: a systematic review. Ann. Clin. Biochem. 41; 441\u2013458.","journal-title":"Ann. Clin. Biochem."},{"issue":"9","key":"9631_CR42","doi-asserted-by":"crossref","first-page":"E1311","DOI":"10.1210\/jc.2014-1120","volume":"9","author":"GN Hendy","year":"2014","unstructured":"Hendy, GN, Canaff, L, Newfield, RS, Tripto-Shkolnik, L, Wong, BY, Lee, BS, Cole, DE. (2014) Codon Arg15 mutations of the AP2S1 gene: common occurrence in familial hypocalciuric hypercalcemia cases negative for calcium-sensing receptor (CASR) mutations. Journal of Clinical Endocrinology and Metabolism. 9(9)E1311\u2013E1315.","journal-title":"Journal of Clinical Endocrinology and Metabolism."},{"key":"9631_CR43","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1056\/NEJMoa1300253","volume":"368","author":"MA Nesbit","year":"2013","unstructured":"Nesbit MA, Hannan FM, Howles SA et al. (2013a) Mutations affecting G-protein alpha 11 in hypercalcemia and hypocalcemia. N. Engl. J. Med. 368; 2476\u20132486.","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"9631_CR44","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.beem.2018.09.010","volume":"32","author":"C Eller-Vainicher","year":"2018","unstructured":"Eller-Vainicher C, Falchetti A. (2018) Management of familial hyperparathyroidism syndromes: MEN1, MEN2, MEN4, HPT-Jaw tumour, Familial isolated hyperparathyroidism, FHH, and neonatal severe hyperparathyroidism. Best Pract Res Clin Endocrinol Metab. Dec;32(6):861-875.","journal-title":"Best Pract Res Clin Endocrinol Metab. Dec"},{"issue":"4","key":"9631_CR45","doi-asserted-by":"crossref","first-page":"697","DOI":"10.4158\/EP12284.RA","volume":"19","author":"MC Shinall","year":"2013","unstructured":"Shinall, Myrick C, Dahir, K. M., Broome, J. T., (2013). Differentiating familial hypocalciuric hypercalcaemia from primary hyperparathyroidism. Endocrine Practice, 19(4), 697-702","journal-title":"Endocrine Practice"},{"issue":"6","key":"9631_CR46","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.beem.2018.09.011","volume":"32","author":"A Falchetti","year":"2018","unstructured":"Falchetti A. (2018) Genetics of parathyroids disorders: Overview. Best Practice & Research Clinical Endocrinology & Metabolism 32(6), 781-790","journal-title":"Best Practice & Research Clinical Endocrinology & Metabolism"},{"key":"9631_CR47","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/ng.2492","volume":"45","author":"MA Nesbit","year":"2013","unstructured":"Nesbit MA, Hannan FM, Howles SA et al. (2013b) Mutations in AP2S1 cause familial hypocalciuric hypercalcemia type 3. Nat. Genet. 45;93\u201399.","journal-title":"Nat. Genet."},{"issue":"5","key":"9631_CR48","doi-asserted-by":"crossref","first-page":"R189","DOI":"10.1530\/EJE-15-1028","volume":"174","author":"B Mayr","year":"2016","unstructured":"Mayr, B., Schnabel, D., D\u00f6rr, H., & Sch\u00f6fl, C. (2016) GENETICS IN ENDOCRINOLOGY: Gain and loss of function mutations of the calcium-sensing receptor and associated proteins: current treatment concepts. European Journal of Endocrinology, 174(5), R189-R208.","journal-title":"European Journal of Endocrinology"},{"key":"9631_CR49","doi-asserted-by":"crossref","first-page":"E707","DOI":"10.1210\/jc.2010-1306","volume":"96","author":"CM Reh","year":"2011","unstructured":"Reh CM, Hendy GN, Cole DE, Jeandron DD. (2011) Neonatal hyper-parathyroidism with a heterozygous calcium-sensing receptor (CASR) R185Q mutation: clinical benefit from cinacalcet. J. Clin. Endocrinol. Metab. 96; E707\u2013E712.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"9631_CR50","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1210\/clinem\/dgz233","volume":"105","author":"S Marx","year":"2020","unstructured":"Marx, S., Sinaii, N. (2020) Neonatal Severe Hyperparathyroidism: Novel Insights From Calcium, PTH, and the CASR Gene. The Journal of Clinical Endocrinology & Metabolism. 105(4);1061-1 078.","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"3","key":"9631_CR51","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1445-2197.1996.tb01142.x","volume":"66","author":"S Wilkinson","year":"1996","unstructured":"Wilkinson S, Young M, Shepherd JJ (1996) The prevalence of MEN-1 in Tasmania. Aust NZ J Surg. 66(3) 141-3.","journal-title":"Aust NZ J Surg."},{"key":"9631_CR52","unstructured":"eviQ Cancer Treatments Online CIN. (2013) Genetic Testing for Heritable Mutations in the Multiple Endocrine Neoplasia (MEN) 1 Gene. [updated 2018 Oct 18], accessed 20th February, 2020."},{"issue":"S1","key":"9631_CR53","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.pathol.2015.12.214","volume":"48","author":"L Prentice","year":"2016","unstructured":"Prentice L, Muller HK, Burgess JR (2016) Parathyroid morphology and staining in Multiple Endocrine Neoplasia-1 (MEN1). Pathology. 48(S1), 80.","journal-title":"Pathology."},{"key":"9631_CR54","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ijsu.2016.05.035","volume":"31","author":"I Christakis","year":"2016","unstructured":"Christakis I, Busaidy NL, Cote GJ et al. (2016) Parathyroid carcinomas and atypical parathyroid neoplasms in MEN1 patients; a clinic\u2013pathologic challenge. The MD Anderson case series and review of the literature. Int. J. Surg. 31;10\u201316.","journal-title":"Int. J. Surg."},{"key":"9631_CR55","volume-title":"SuperMEN1. Advances in Experimental Medicine and Biology","author":"C Davenport","year":"2009","unstructured":"Davenport C., Agha A. (2009) The Role of Menin in Parathyroid Tumorigenesis. In: Balogh K., Patocs A. (eds) SuperMEN1. Advances in Experimental Medicine and Biology, vol 668. Springer, New York"},{"issue":"7","key":"9631_CR56","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1210\/jcem.85.7.6688","volume":"85","author":"M Bhuiyan","year":"2007","unstructured":"Bhuiyan, M., Sato, M., Murao, K., Imachi, H., Namihira, H., Takahara, J. (2007) Expression of Menin in Parathyroid Tumors, The Journal of Clinical Endocrinology & Metabolism, 85(7): 2615\u20132619","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"3","key":"9631_CR57","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00428-017-2158-3","volume":"471","author":"VK Grolmusz","year":"2017","unstructured":"Grolmusz VK, Borka K, Kovesdi A et al. (2017) MEN1 mutations and potentially MEN1-targeting miRNAs are responsible for menin deficiency in sporadic and MEN1 syndrome-associated primary hyperparathyroidism. Virchows Arch 471(3) 401-411.","journal-title":"Virchows Arch"},{"key":"9631_CR58","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1093\/hmg\/6.7.1169","volume":"6","author":"SK Agarwal","year":"1997","unstructured":"Agarwal SK, Kester MB, Debelenko LV et al. (1997) Germline mutations of the MEN1 gene in multiple endocrine neoplasia type 1 and related states. Hum. Mol. Genet. 6; 1169\u20131175.","journal-title":"Hum. Mol. Genet."},{"key":"9631_CR59","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1126\/science.276.5311.404","volume":"27","author":"SC Chandrasekharappa","year":"1997","unstructured":"Chandrasekharappa SC, Guru SC, Manickam P et al. (1997) Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 27; 404\u2013407.","journal-title":"Science"},{"key":"9631_CR60","doi-asserted-by":"crossref","unstructured":"Falchetti A. (2017) Genetics of multiple endocrine neoplasia type 1 syndrome: what\u2019s new and what\u2019s old. F1000Research 24(6) Faculty Rev-73.","DOI":"10.12688\/f1000research.7230.1"},{"issue":"3","key":"9631_CR61","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1677\/ERC-10-0028","volume":"17","author":"V Corbo","year":"2010","unstructured":"Corbo, V., Dalai, I., Scardoni, M., et al (2010). MEN1 in pancreatic endocrine tumors: analysis of gene and protein status in 169 sporadic neoplasms reveals alterations in the vast majority of cases, Endocrine-Related Cancer, 17(3), 771-783.","journal-title":"Endocrine-Related Cancer"},{"issue":"2","key":"9631_CR62","doi-asserted-by":"crossref","first-page":"T15","DOI":"10.1530\/ERC-17-0266","volume":"25","author":"C Guerin","year":"2018","unstructured":"Guerin, C, Romanet P, Taieb D, et al. (2018) Looking Beyond the Thyroid: Advances in the Understanding of Pheochromocytoma and Hyperparathyroidism Phenotypes in MEN2 and of Non-MEN2 Familial Forms. Endocrine-related cancer 25(2): T15\u2013T28.","journal-title":"Endocrine-related cancer"},{"key":"9631_CR63","doi-asserted-by":"publisher","unstructured":"Machens, A, Elwerr M, Lorenz K, et al. (2020) 100-Year Evolution of Precision Medicine and Surgery for Multiple Endocrine Neoplasia Type 2A. Endocrine doi: https:\/\/doi.org\/10.1007\/s12020-020-02232-5.","DOI":"10.1007\/s12020-020-02232-5"},{"key":"9631_CR64","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1093\/hmg\/2.7.851","volume":"2","author":"H Donis-Keller","year":"1993","unstructured":"Donis-Keller H, Dou S, Chi D et al. (1993) Mutations in the RET protooncogene are associated with MEN2A and FMTC Hum. Mol. Genet. 2; 851\u2013856.","journal-title":"Hum. Mol. Genet."},{"key":"9631_CR65","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/363458a0","volume":"363","author":"LM Mulligan","year":"1993","unstructured":"Mulligan LM, Kwok JB, Healey CS et al. (1993) Germline mutations of the RET protooncogene in multiple endocrine neoplasia type 2A. Nature 363; 458\u2013460.","journal-title":"Nature"},{"key":"9631_CR66","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1073\/pnas.91.4.1579","volume":"91","author":"KM Carlson","year":"1994","unstructured":"Carlson KM, Dou S, Chi D et al. (1994) Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B. Proc. Natl Acad. Sci. USA 91; 1579\u20131583.","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"9631_CR67","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1001\/jama.1996.03540190047028","volume":"276","author":"C Eng","year":"1996","unstructured":"Eng C, Clayton D, Schuffenecker I et al. (1996) The relationships between specific RET protooncogene mutations and disease phenotype in multiple endocrine neoplasia 2. International RET Mutation Consortium analysis. JAMA 276; 1575\u20131579.","journal-title":"JAMA"},{"issue":"3","key":"9631_CR68","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/cen.12513","volume":"81","author":"D Ta\u00efeb","year":"2014","unstructured":"Ta\u00efeb, D, Kebebew, E, Castinetti, F, et al. (2014) Diagnosis and Preoperative Imaging of Multiple Endocrine Neoplasia Type 2: Current Status and Future Directions. Clinical Endocrinology 81(3): 317\u2013328.","journal-title":"Clinical Endocrinology"},{"key":"9631_CR69","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/humu.21385","volume":"32","author":"K Frank-Raue","year":"2011","unstructured":"Frank-Raue K, Rybicki LA, Erlic C et al. (2011) Risk profiles and prevalence estimations in multiple endocrine neoplasia type 2A caused by germline RET mutations located in exon 10. Hum. Mutat. 32;51\u201358.","journal-title":"Hum. Mutat."},{"key":"9631_CR70","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/cen.12978","volume":"84","author":"A Machens","year":"2016","unstructured":"Machens A, Dralle H. (2016) Variability in penetrance of multiple endocrine neoplasia 2A with amino acid substitutions in RET codon 634. Clin. Endocrinol. 84; 210\u2013215.","journal-title":"Clin. Endocrinol."},{"key":"9631_CR71","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/thy.2014.0335","volume":"25","author":"SA Wells","year":"2015","unstructured":"Wells SA, Asa SL, Dralle H et al. (2015) Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid 25; 567\u2013609.","journal-title":"Thyroid"},{"key":"9631_CR72","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1046\/j.1365-2265.1997.3421147.x","volume":"47","author":"PJ Jenkins","year":"1997","unstructured":"Jenkins PJ, Satta MA, Simmgen M et al. (1997) Metastatic parathyroid carcinoma in the MEN2A syndrome. Clin. Endocrinol. 47; 747\u2013751.","journal-title":"Clin. Endocrinol."},{"key":"9631_CR73","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s12022-003-0017-z","volume":"14","author":"A Khan","year":"2003","unstructured":"Khan A, Tischler AS, Patwardhan NA, DeLellis RA. (2003) Calcitonin immunoreactivity in neoplastic and hyperplastic parathyroid glands: an immunohistochemical study. Endocrinol. Pathol. 14; 249\u2013255.","journal-title":"Endocrinol. Pathol."},{"key":"9631_CR74","doi-asserted-by":"crossref","first-page":"15558","DOI":"10.1073\/pnas.0603877103","volume":"103","author":"NS Pellegata","year":"2006","unstructured":"Pellegata NS, Quintanilla-Martinez L, Siggelkow H et al. (2006) Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans. Proc. Natl Acad. Sci. USA 103; 15558\u201315563.","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"9631_CR75","first-page":"781","volume":"36","author":"M Lee","year":"2013","unstructured":"Lee M, Pellegata NS. (2013a) Multiple endocrine neoplasia syndromes associated with mutation of p27. J. Endocrinol. Invest. 36; 781\u2013787.","journal-title":"J. Endocrinol. Invest."},{"key":"9631_CR76","first-page":"510985","volume":"2015","author":"MS Elston","year":"2015","unstructured":"Elston MS, Meyer-Rochow GY, Dray M, Swarbick M, Conaglen JV. (2015) Early onset primary hyperparathyroidism associated with a novel germline mutation in CDKN1B. Case Rep. Endocrinol. 2015; 510985.","journal-title":"Case Rep. Endocrinol."},{"key":"9631_CR77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/EC-14-0116","volume":"4","author":"E Pardi","year":"2015","unstructured":"Pardi E, Mariotti S, Pellegata NS et al. (2015) Functional characterization of a CDKN1B mutation in a Sardinian kindred with multiple endocrine neoplasia type 4 (MEN4). Endocr. Connect. 4;1\u20138.","journal-title":"Endocr. Connect."},{"key":"9631_CR78","doi-asserted-by":"crossref","first-page":"K7","DOI":"10.1530\/EJE-14-0080","volume":"171","author":"F Tonelli","year":"2014","unstructured":"Tonelli F, Giudici F, Giusti F et al. (2014) A heterozygous frameshift mutation in exon 1 of CDKN1B in a patient affected by MEN4 syndrome. Eur. J. Endocrinol. 171;K7\u2013K17.","journal-title":"Eur. J. Endocrinol."},{"key":"9631_CR79","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0079-6123(10)82013-8","volume":"182","author":"S Molatore","year":"2010","unstructured":"Molatore S, Pellegata NS. (2010) The MENX syndrome and p27: relationship with multiple endocrine neoplasia. Progr. Brain Res. 182; 295\u2013320.","journal-title":"Progr. Brain Res."},{"key":"9631_CR80","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000320366","volume":"93","author":"I Marinoni","year":"2011","unstructured":"Marinoni I, Pellegata NS. (2011) p27kip1: a new multiple endocrine neoplasia gene? Neuroendocrinology 93;19\u201328.","journal-title":"Neuroendocrinology"},{"issue":"9","key":"9631_CR81","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1210\/jc.2019-00082","volume":"104","author":"V Frederiksen","year":"2019","unstructured":"Frederiksen, V, Rossing, M, Hermann, P, et al. (2019) Clinical Features of Multiple Endocrine Neoplasia Type 4: Novel Pathogenic Variant and Review of Published Cases. The Journal of Clinical Endocrinology & Metabolism 104(9):3637\u20133646.","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"1","key":"9631_CR82","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000371819","volume":"103","author":"MH Schernthaner-Reiter","year":"2016","unstructured":"Schernthaner-Reiter MH, Trivellin G, Stratakis CA. (2016) MEN1, MEN4, and Carney Complex: Pathology and Molecular Genetics. Neuroendocrinology. 103(1):18\u201331.","journal-title":"Neuroendocrinology."},{"key":"9631_CR83","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000345670","volume":"41","author":"M Lee","year":"2013","unstructured":"Lee M, Pellegata NS. (2013b) Multiple endocrine neoplasia type 4. Front Horm Res. 41:63-78.","journal-title":"Front Horm Res."},{"issue":"10","key":"9631_CR84","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1530\/ERC-17-0243","volume":"24","author":"R Alrezk","year":"2017","unstructured":"Alrezk R Hannah-Shmouni F, Stratakis CA. (2017) MEN4 and CDKN1B mutations: The latest of the MEN syndromes. Endocrine related cancer. 24(10):195-208","journal-title":"Endocrine related cancer."},{"issue":"2","key":"9631_CR85","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s12020-016-0941-6","volume":"55","author":"S Borsari","year":"2017","unstructured":"Borsari S, Pardi E, Pellengata NS, et al. (2017) Loss of p27 expression is associated with MEN1 gene mutations in sporadic parathyroid adenomas. Endocrine. 55(2);386-397","journal-title":"Endocrine."},{"key":"9631_CR86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-200201000-00001","volume":"81","author":"WF Simonds","year":"2002","unstructured":"Simonds WF, James-Newton LA, Agarwal SK et al. (2002) Familial isolated hyperparathyroidism. Clinical and genetic characteristics of 36 kindreds. Medicine (Baltimore) 81;1\u201326.","journal-title":"Medicine (Baltimore)"},{"key":"9631_CR87","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1136\/jmg.2003.016725","volume":"41","author":"J Warner","year":"2004","unstructured":"Warner J, Epstein M, Sweet A et al. (2004) Genetic testing in familial isolated hyperparathyroidism: unexpected results and their implications. J. Med. Genet. 41; 155\u2013160.","journal-title":"J. Med. Genet."},{"key":"9631_CR88","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.ajhg.2016.08.018","volume":"99","author":"B Guan","year":"2016","unstructured":"Guan B, Welch JM, Sapp J et al. (2016) GCM2-Activating mutations in familial isolated hyperparathyroidism. Am. J. Hum. Genet. 99; 1034\u20131044.","journal-title":"Am. J. Hum. Genet."}],"container-title":["Endocrine Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-020-09631-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12022-020-09631-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-020-09631-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T01:17:42Z","timestamp":1622164662000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12022-020-09631-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,28]]},"references-count":88,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["9631"],"URL":"https:\/\/doi.org\/10.1007\/s12022-020-09631-4","relation":{},"ISSN":["1046-3976","1559-0097"],"issn-type":[{"value":"1046-3976","type":"print"},{"value":"1559-0097","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,28]]},"assertion":[{"value":"28 May 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}